← back to search

Eugenia Martínez‐Hernández

Hospital Clínic de Barcelona · ES
Area of research
Neurology · Pathology and Forensic Medicine
Research interest
Research interests include Autoimmune Neurological Disorders and Treatments, Peripheral Neuropathies and Disorders, Multiple Sclerosis Research Studies, and Long-Term Effects of COVID-19.
h-index
54
citations
16,230
works
160
NIH funding
primary concept
email

Recent publications

Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis
Neurology Neuroimmunology & Neuroinflammation 2025cited by 7position: middledoi
Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies
Brain 2023cited by 68position: middledoi
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
Neurology 2022cited by 81position: middledoi
Encephalitis with Autoantibodies against the Glutamate Kainate Receptor (GluK2) (S41.002)
Neurology 2022cited by 1position: middledoi
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
BMJ 2021cited by 212position: middledoi
Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study
Brain 2021cited by 74position: middledoi
Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy
Neurology Neuroimmunology & Neuroinflammation 2021cited by 62position: middledoi
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors <scp>GluK2</scp>
Annals of Neurology 2021cited by 54position: middledoi
Seizure-related 6 homolog like 2 autoimmunity
Neurology Neuroimmunology & Neuroinflammation 2020cited by 58position: middledoi
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis
The Lancet Neurology 2018cited by 641position: middledoi
Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies
JAMA Neurology 2015cited by 224position: middledoi
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
The Lancet Neurology 2013cited by 3,073position: middledoi
Encephalitis and antibodies to dipeptidyl‐peptidase–like protein‐6, a subunit of Kv4.2 potassium channels
Annals of Neurology 2012cited by 371position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Francesc Graus · Consorci Institut D'Investigacions Biomediques August Pi I Sunyer6 papers (2012–2022)Josep Dalmau · Centro de Investigación Biomédica en Red6 papers (2012–2022)Albert Saiz · Hospital Clínic de Barcelona5 papers (2013–2022)Maarten J. Titulaer · Erasmus MC4 papers (2013–2022)Thaís Armangué · Hospital Sant Joan de Déu Barcelona4 papers (2013–2022)Núria Gresa‐Arribas · Niigata University3 papers (2012–2015)Lídia Sabater · Centro de Investigación Biomédica en Red3 papers (2020–2022)Jesús Planagumà · Fundació Clínic per a la Recerca Biomèdica3 papers (2020–2022)Mar Guasp · Catholics for Choice3 papers (2020–2022)Jon Landa · Onkologikoa3 papers (2020–2022)Peter Fuhr · Oak Ridge National Laboratory2 papers (2021–2022)Myrna R. Rosenfeld · University of Pennsylvania2 papers (2012–2013)Xavier Gasull · Universitat de Barcelona2 papers (2021–2022)Takayasu Mishima · University of Alabama at Birmingham2 papers (2021–2022)Jérôme Honnorat · Université Claude Bernard Lyon 12 papers (2021–2022)Federico Míguez‐Cabello · McGill University2 papers (2021–2022)Rita J. Balice‐Gordon · MC2 Therapeutics (Denmark)2 papers (2012–2013) · 2 papers (2021–2022)Vladimir Krajinović · Université Laval2 papers (2021–2022)Frauke Zipp · Department of Physics, Mathematics and Informatics2 papers (2021–2022)